Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Epoetin-alfa Erythropoietin Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4306017
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 134 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Epoetin-alfa Erythropoietin market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Epoetin-alfa Erythropoietin market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Anemia
Kidney Disorders
Other

Segmented by End User/Segment
Hospital
Clinic

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Roche
LG Life Sciences
Kyowa Hakko Kirin
Johnson & Johnson
Galenica
Emcure
Biocon
Amgen
3SBio


Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Epoetin-alfa Erythropoietin Market Status and Forecast (2016-2027)
      • 1.3.2 Global Epoetin-alfa Erythropoietin Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Epoetin-alfa Erythropoietin Supply by Company

    • 2.1 Global Epoetin-alfa Erythropoietin Sales Volume by Company
    • 2.2 Global Epoetin-alfa Erythropoietin Sales Value by Company
    • 2.3 Global Epoetin-alfa Erythropoietin Price by Company
    • 2.4 Epoetin-alfa Erythropoietin Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Epoetin-alfa Erythropoietin Market Status by Category

    • 3.1 Epoetin-alfa Erythropoietin Category Introduction
      • 3.1.1 Anemia
      • 3.1.2 Kidney Disorders
      • 3.1.3 Other
    • 3.2 Global Epoetin-alfa Erythropoietin Market by Category
      • 3.2.1 Global Epoetin-alfa Erythropoietin Sales Volume by Category (2016-2021)
      • 3.2.2 Global Epoetin-alfa Erythropoietin Sales Value by Category (2016-2021)
      • 3.2.3 Global Epoetin-alfa Erythropoietin Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Epoetin-alfa Erythropoietin Market Status by End User/Segment

    • 4.1 Epoetin-alfa Erythropoietin Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinic
    • 4.2 Global Epoetin-alfa Erythropoietin Market by End User/Segment
      • 4.2.1 Global Epoetin-alfa Erythropoietin Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Epoetin-alfa Erythropoietin Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Epoetin-alfa Erythropoietin Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Epoetin-alfa Erythropoietin Market Status by Region

    • 5.1 Global Epoetin-alfa Erythropoietin Market by Region
      • 5.1.1 Global Epoetin-alfa Erythropoietin Sales Volume by Region
      • 5.1.2 Global Epoetin-alfa Erythropoietin Sales Value by Region
    • 5.2 North America Epoetin-alfa Erythropoietin Market Status
    • 5.3 Europe Epoetin-alfa Erythropoietin Market Status
    • 5.4 Asia Pacific Epoetin-alfa Erythropoietin Market Status
    • 5.5 Central & South America Epoetin-alfa Erythropoietin Market Status
    • 5.6 Middle East & Africa Epoetin-alfa Erythropoietin Market Status

    6 North America Epoetin-alfa Erythropoietin Market Status

    • 6.1 North America Epoetin-alfa Erythropoietin Market by Country
      • 6.1.1 North America Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 6.1.2 North America Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Epoetin-alfa Erythropoietin Market Status

    • 7.1 Europe Epoetin-alfa Erythropoietin Market by Country
      • 7.1.1 Europe Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Epoetin-alfa Erythropoietin Market Status

    • 8.1 Asia Pacific Epoetin-alfa Erythropoietin Market by Country
      • 8.1.1 Asia Pacific Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Epoetin-alfa Erythropoietin Market Status

    • 9.1 Central & South America Epoetin-alfa Erythropoietin Market by Country
      • 9.1.1 Central & South America Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Epoetin-alfa Erythropoietin Market Status

    • 10.1 Middle East & Africa Epoetin-alfa Erythropoietin Market by Country
      • 10.1.1 Middle East & Africa Epoetin-alfa Erythropoietin Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Epoetin-alfa Erythropoietin Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Epoetin-alfa Erythropoietin Manufacturing Cost Analysis
    • 11.5 Epoetin-alfa Erythropoietin Sales Channel and Distributors Analysis
      • 11.5.1 Epoetin-alfa Erythropoietin Sales Channel
      • 11.5.2 Epoetin-alfa Erythropoietin Distributors
    • 11.6 Epoetin-alfa Erythropoietin Downstream Major Buyers

    12 Global Epoetin-alfa Erythropoietin Market Forecast by Category and by End User/Segment

    • 12.1 Global Epoetin-alfa Erythropoietin Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Epoetin-alfa Erythropoietin Forecast by Category
      • 12.2.1 Global Epoetin-alfa Erythropoietin Sales Volume Forecast by Category
      • 12.2.2 Global Epoetin-alfa Erythropoietin Sales Value Forecast by Category
      • 12.2.3 Global Epoetin-alfa Erythropoietin Price Forecast by Category
    • 12.3 Global Epoetin-alfa Erythropoietin Forecast by End User/Segment
      • 12.3.1 Global Epoetin-alfa Erythropoietin Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Epoetin-alfa Erythropoietin Sales Value Forecast by End User/Segment
      • 12.3.3 Global Epoetin-alfa Erythropoietin Price Forecast by End User/Segment

    13 Global Epoetin-alfa Erythropoietin Market Forecast by Region/Country

    • 13.1 Global Epoetin-alfa Erythropoietin Market Forecast by Region (2022-2027)
      • 13.1.1 Global Epoetin-alfa Erythropoietin Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Epoetin-alfa Erythropoietin Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Roche
      • 14.1.1 Company Information
      • 14.1.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.1.3 Roche Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 LG Life Sciences
      • 14.2.1 Company Information
      • 14.2.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.2.3 LG Life Sciences Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Kyowa Hakko Kirin
      • 14.3.1 Company Information
      • 14.3.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.3.3 Kyowa Hakko Kirin Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Johnson & Johnson
      • 14.4.1 Company Information
      • 14.4.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.4.3 Johnson & Johnson Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Galenica
      • 14.5.1 Company Information
      • 14.5.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.5.3 Galenica Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Emcure
      • 14.6.1 Company Information
      • 14.6.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.6.3 Emcure Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Biocon
      • 14.7.1 Company Information
      • 14.7.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.7.3 Biocon Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Amgen
      • 14.8.1 Company Information
      • 14.8.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.8.3 Amgen Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 3SBio
      • 14.9.1 Company Information
      • 14.9.2 Epoetin-alfa Erythropoietin Product Introduction
      • 14.9.3 3SBio Epoetin-alfa Erythropoietin Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Summary:
      Get latest Market Research Reports on Epoetin-alfa Erythropoietin. Industry analysis & Market Report on Epoetin-alfa Erythropoietin is a syndicated market report, published as Dynamics in Post-pandemic Global Epoetin-alfa Erythropoietin Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Epoetin-alfa Erythropoietin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,300.56
      3,450.84
      4,601.12
      2,738.62
      4,107.93
      5,477.24
      453,168.60
      679,752.90
      906,337.20
      250,796.80
      376,195.20
      501,593.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report